eicosanoid general
mediate physiologic and pathalogic repsonses
made everywhere except blood
short 1/2 life, function autocrine and paracrine signalling
Prostanoids
Leukotrienes
Expoxides
3rd letter is ring structure, number is number of double bonds 1,2,3
Creation of eicosanoids
draw out with enzymes
activation of Gq protein couples receptor
-increased Ca
Membrane phospholipid
-Phospholipase A2 (LR)
Arachodonic Acid, DGLA(linoleic), EPA(linelenic)
(linoleic-both less and more inflammatory)
TWO PATHS
-5-lipoxygenase
Leukotrienes
Cysteinyl Leukotrienes
OR
-Cyclooxygenase 1or2
-Peroxidase
(PGH Synthase-1st com step) requires 2 O2 (cyclization)
PGH2
-PGH a substrate for prostanoid synthssis
how do cells use prostanoids
platelets can use them to recruit eachother
endothelial cells can release different ones to inhibit platelet aggregation or the other
leukotrienes
-5 lipoxygenase (ZYFLO INHIBITS)-prevent asthma
Leukotrienes
cysteinyl leukotrienes
-act at cell surface receptors (SINGLULAIR INHIBITS)-treat asthma
-contract bronchial and vascular smooth muscle
-enhance mucus secresion in airway and gut
-recruit leukocytes
-increase cap perm
where are each made and what they affect
endothelial cells make PGI2
platelets produce TXA2
PG and TX-GPCRs- IP3/DAG increase Ca and increase PKC
PGI (cyclin) PGE2 PGD2 - Gs linked receptors (adenylate cyclase increase cAMP)
degradation
short 1/2 life or 15-hydroxyprostaglandin dehydrogenase
-high levels in pulmnonary cap bed
Cox1 Vs Cox2
Cox 1 smaller substrate binding site
Cox 2 larger binding site (can design drugs that bind only to Cox2)
gastric damage occurs when both inhibited
Cox inhibitors
NSAIDS
Aspirin (NSAID) COX1 and COX2 inhibition
ibuprofen/naproxen COX1 and COX2
-competetive inhibitor of 1/2
A, A, A
Celebrex: COX 2 ONLY
-substrate channel cox2 INFLAMMATION ONLY
Cox inhibitors non nsaids
Tylenol: NEITHER COX
Glucocorticoids: decrease PLA2 activity, decrease COX2 synthesis